185 related articles for article (PubMed ID: 32320927)
1. Overview of « druggable » alterations by histological subtypes of sarcomas and connective tissue intermediate malignancies.
Penel N; Lebellec L; Blay JY; Robin YM
Crit Rev Oncol Hematol; 2020 Jun; 150():102960. PubMed ID: 32320927
[TBL] [Abstract][Full Text] [Related]
2. Current Molecular Targeted Therapies for Bone and Soft Tissue Sarcomas.
Nakano K; Takahashi S
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29510588
[TBL] [Abstract][Full Text] [Related]
3. Novel pathways and molecular targets for the treatment of sarcoma.
Frith AE; Hirbe AC; Van Tine BA
Curr Oncol Rep; 2013 Aug; 15(4):378-85. PubMed ID: 23661264
[TBL] [Abstract][Full Text] [Related]
4. Histology-specific therapy for advanced soft tissue sarcoma and benign connective tissue tumors.
Silk AW; Schuetze SM
Curr Treat Options Oncol; 2012 Sep; 13(3):285-98. PubMed ID: 22610342
[TBL] [Abstract][Full Text] [Related]
5. The past, present, and future of cytotoxic chemotherapy and pathway-directed targeted agents for soft tissue sarcoma.
Ryan CW; Desai J
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714556
[TBL] [Abstract][Full Text] [Related]
6. [Targeted treatment of rare connective tissue tumors and sarcomas].
Cassier P; Pissaloux D; Alberti L; Ray-Coquard I; Blay JY
Bull Cancer; 2010 Jun; 97(6):693-700. PubMed ID: 20497911
[TBL] [Abstract][Full Text] [Related]
7. Targeted agents for sarcoma: is individualized therapy possible in such a diverse tumor type?
Riedel RF
Semin Oncol; 2011 Oct; 38 Suppl 3():S30-42. PubMed ID: 22055970
[TBL] [Abstract][Full Text] [Related]
8. Targeted Chemotherapy in Bone and Soft-Tissue Sarcoma.
Harwood JL; Alexander JH; Mayerson JL; Scharschmidt TJ
Orthop Clin North Am; 2015 Oct; 46(4):587-608. PubMed ID: 26410647
[TBL] [Abstract][Full Text] [Related]
9. Emerging therapies for sarcoma.
Movva S
Curr Probl Cancer; 2013; 37(2):87-101. PubMed ID: 23719333
[TBL] [Abstract][Full Text] [Related]
10. Treatment of advanced soft tissue sarcoma: conventional agents and promising new drugs.
Wagner A
J Natl Compr Canc Netw; 2007 Apr; 5(4):401-10. PubMed ID: 17442231
[TBL] [Abstract][Full Text] [Related]
11. Soft tissue sarcomas: are all soft tissue sarcomas treated with the same drugs?
Blay JY; Cassier PA; Ray-Coquard I
Eur J Cancer; 2011 Sep; 47 Suppl 3():S385-8. PubMed ID: 21944026
[No Abstract] [Full Text] [Related]
12. Treatment of adult soft tissue sarcoma: old concepts, new insights, and potential for drug discovery.
Aragon-Ching JB; Maki RG
Cancer Invest; 2012 May; 30(4):300-8. PubMed ID: 22480231
[TBL] [Abstract][Full Text] [Related]
13. Update of phase I study of imatinib (STI571) in advanced soft tissue sarcomas and gastrointestinal stromal tumors: a report of the EORTC Soft Tissue and Bone Sarcoma Group.
van Oosterom AT; Judson IR; Verweij J; Stroobants S; Dumez H; Donato di Paola E; Sciot R; Van Glabbeke M; Dimitrijevic S; Nielsen OS;
Eur J Cancer; 2002 Sep; 38 Suppl 5():S83-7. PubMed ID: 12528778
[TBL] [Abstract][Full Text] [Related]
14. Current and advancing systemic treatment options for soft tissue sarcomas.
Harris SJ; Benson C; Jones RL
Expert Opin Pharmacother; 2015; 16(13):2023-37. PubMed ID: 26255951
[TBL] [Abstract][Full Text] [Related]
15. Targeted therapy in bone and soft tissue sarcoma in children and adolescents.
Thompson PA; Chintagumpala M
Curr Oncol Rep; 2012 Apr; 14(2):197-205. PubMed ID: 22302601
[TBL] [Abstract][Full Text] [Related]
16. [Molecular biology of sarcoma and therapeutic choices].
Dufresne A; Cassier P; Heudel P; Pissaloux D; Wang Q; Blay JY; Ray-Coquard I
Bull Cancer; 2015 Jan; 102(1):6-16. PubMed ID: 25609490
[TBL] [Abstract][Full Text] [Related]
17. KIT and PDGF as targets.
Verweij J
Cancer Treat Res; 2004; 120():117-27. PubMed ID: 15217221
[No Abstract] [Full Text] [Related]
18. [Targeted therapies in soft-tissue and visceral sarcomas].
Emile JF
Ann Pathol; 2009 Nov; 29 Spec No 1():S81-2. PubMed ID: 19887262
[No Abstract] [Full Text] [Related]
19. Fifty years of advances in sarcoma treatment: moving the needle from conventional chemotherapy to targeted therapy.
Patel SR
Am Soc Clin Oncol Educ Book; 2014; ():259-62. PubMed ID: 24857084
[TBL] [Abstract][Full Text] [Related]
20. Individualizing systemic therapy for advanced soft tissue sarcomas based on tumor histology and biology.
Haddox CL; Riedel RF
Expert Rev Anticancer Ther; 2020 Jan; 20(1):5-8. PubMed ID: 31859537
[No Abstract] [Full Text] [Related]
[Next] [New Search]